ArticleMicrobial genomics2015
Single molecule real-time sequencing of
Article in Microbial genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 81 citations in OpenAlex.
- Large- and small-scale population structure ofApplied and environmental microbiology · 2025Article
- PthXo2B Orthologue Tal7 of Xanthomonas oryzae pv. oryzae Strain IX-221 Acts as a Major Virulence Factor in Indica Rice Without Activating a Clade III SWEET Gene.Molecular plant pathology · 2025Article
- Investigating Polyhydroxyalkanoate Synthesis for Insights into Drug Resistance inInternational journal of molecular sciences · 2025Article
- Activation of three targets by a TAL effector confers susceptibility to bacterial blight of cotton.Nature communications · 2025Article
- Prevalence and diversity of TAL effector-like proteins in fungal endosymbioticMicrobial genomics · 2024Article
- Analysis of soft rotFrontiers in microbiology · 2024Article
- Genetic Structure and TALome Analysis Highlight a High Level of Diversity in Burkinabe Xanthomonas Oryzae pv. oryzae Populations.Rice (New York, N.Y.) · 2023Article
- Complete Genomic Sequence ofInternational journal of molecular sciences · 2023Article
- Assembling highly repetitive Xanthomonas TALomes using Oxford Nanopore sequencing.BMC genomics · 2023Article
- Long-read genome sequence data of pomegranate bacterial blight pathogenData in brief · 2023Article
- CRISPR/FnCas12a-mediated efficient multiplex and iterative genome editing in bacterial plant pathogens without donor DNA templates.PLoS pathogens · 2023Article
- Diversity of transcription activator-like effectors and pathogenicity in strains of Xanthomonas oryzae pv. oryzicola from Yunnan.World journal of microbiology & biotechnology · 2022Article
- Comparative Genomic Analysis of TwoFrontiers in microbiology · 2022Article
- Cassava diseases caused by Xanthomonas phaseoli pv. manihotis and Xanthomonas cassavae.Molecular plant pathology · 2021Review
- Resistance and susceptibility QTL identified in a rice MAGIC population by screening with a minor-effect virulence factor from Xanthomonas oryzae pv. oryzae.Plant biotechnology journal · 2021Article
- Complete Genome Assemblies of AllFrontiers in microbiology · 2021Article
- Identification of a virulence tal gene in the cotton pathogen, Xanthomonas citri pv. malvacearum strain Xss-VBMC microbiology · 2020Article
- The Green Revolution shaped the population structure of the rice pathogen Xanthomonas oryzae pv. oryzae.The ISME journal · 2020Article
- AnFrontiers in microbiology · 2020Article
- Broad-spectrum resistance to bacterial blight in rice using genome editing.Nature biotechnology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 1 country.
Funding
Abstract
Pathogen-injected, direct transcriptional activators of host genes, TAL (transcription activator-like) effectors play determinative roles in plant diseases caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.